Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis

被引:0
|
作者
Mikhail M. Kostik
Olga L. Kopchak
Irina A. Chikova
Eugenia A. Isupova
Alexander Y. Mushkin
机构
[1] Saint-Petersburg State Pediatric Medical University,
[2] Kirov’s Regional Children’s Hospital,undefined
[3] Science Research Institute of Phthisiopulmonology,undefined
来源
Rheumatology International | 2019年 / 39卷
关键词
Chronic non-bacterial osteomyelitis; Pamidronate; TNFα-inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic non-bacterial osteomyelitis (CNO) is a chronic inflammatory bone disease which usually manifests in children and adolescents. There are a few data about pathogenesis and treatment. The aim of the study to compare the efficacy of different treatment approaches in pediatric CNO cohort patient. Fifty two children (25 boys and 27 girls) with CNO with average age at the onset of the disease 8.4 years (5.4; 11.0), number of foci − 3.0 (2.0; 6.0, incl. multifocal cases in 80.8%). Non-steroid anti-inflammatory drugs (NSAID) was the first-line treatment for non-vertebral cases, as well as pamidronate (PAM) for vertebral involvement. Second-line treatment includes sulfasalazine (SSZ), methotrexate (MTX), PAM and tumor necrosis factor-α inhibitors (TNFα-inh). We evaluated the dynamics of pain, patient’s and physician’s (MDVAS) assessment with visual-analog scale (VAS) and ability to each medication to achieve remission of CNO activity. According to the NSAID, MTX, SSZ, PAM and TNFα-inh groups the following data were registered: patient’s VAS: − 14.2% (p = 0.05), − 50.0% (p = 0.04), − 23.1 (p = 0.89), − 83.3% (p = 0.0001), − 73.6% (p = 0.0007); painVAS: − 21.9% (p = 0.01), − 18.6% (p = 0.13), + 36.4 (p = 0.89), − 79.7% (p = 0.00016), − 74.1%, (p = 0.0015); MDVAS: − 13.8% (p = 0.13); − 56.4% (p = 0.09), + 30.8% (p = 0.89), − 74.7%, (p = 0.0001), − 82.1 (p = 0.0015) respectively. The ability of each treatment strategy to achieve the CNO remission was 52.6%, 44.4%, 57,1%, 88.8% and 73.3%, respectively (log-rank test, p = 0.001). The efficacy of treatment approaches for CNO depended on the severity of the disease. NSAID, methotrexate, and sulfasalazine were effective in forms without spine involvement, but pamidronate and TNF-a inhibitors were useful in vertebral forms of CNO. Pamidronate and TNF-a inhibitors more extensively suppressed CNO activity. The randomized controlled trials for assessment of the efficacy and safety of these medications is mandatory to confirm these results.
引用
收藏
页码:89 / 96
页数:7
相关论文
共 50 条
  • [21] Response of Different Treatment Protocols to Treat Chronic Non-Bacterial Osteomyelitis (CNO) of the Mandible in Adult Patients: A Systematic Review
    Timme, Maximilian
    Bohner, Lauren
    Huss, Sebastian
    Kleinheinz, Johannes
    Hanisch, Marcel
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (05)
  • [22] Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy
    Bouchalova, Katerina
    Pytelova, Zuzana
    BIOMEDICAL PAPERS-OLOMOUC, 2024, 168 (03): : 191 - 199
  • [23] The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)—a systematic review
    Sigrun Ruth Hofmann
    Franz Kapplusch
    Katrin Mäbert
    Christian Michael Hedrich
    Molecular and Cellular Pediatrics, 4 (1)
  • [24] Chronic non-bacterial osteomyelitis: a comparative study between children and adults
    Andrea Skrabl-Baumgartner
    Peter Singer
    Theresa Greimel
    Gregor Gorkiewicz
    Josef Hermann
    Pediatric Rheumatology, 17
  • [25] New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO
    Christian M. Hedrich
    Henner Morbach
    Christiane Reiser
    Hermann J. Girschick
    Current Rheumatology Reports, 2020, 22
  • [26] New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO
    Hedrich, Christian M.
    Morbach, Henner
    Reiser, Christiane
    Girschick, Hermann J.
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (09)
  • [27] Chronic non-bacterial osteomyelitis: a comparative study between children and adults
    Skrabl-Baumgartner, Andrea
    Singer, Peter
    Greimel, Theresa
    Gorkiewicz, Gregor
    Hermann, Josef
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [28] Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis
    Ferrara, G.
    Insalaco, A.
    Pardeo, M.
    Cattalini, M.
    La Torre, F.
    Finetti, M.
    Ricci, F.
    Alizzi, C.
    Teruzzi, B.
    Simonini, G.
    Messia, V.
    Pastore, S.
    Morra, L.
    Cimaz, R.
    Gattorno, M.
    Taddio, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 366 - 369
  • [29] Chronic non-bacterial osteomyelitis of the mandible - orthodontic considerations and management: A case report
    Schwabe, Saskia Andrea
    Booth, Sean
    Caldwell, Susi
    JOURNAL OF ORTHODONTICS, 2024, : 415 - 423
  • [30] Chronic non-bacterial osteomyelitis: another disease associated with MEFV gene mutations
    Avar-Aydin, P. O.
    Ozcakar, Z. B.
    Cakar, N.
    Fitoz, S.
    Yalcinkaya, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : S112 - S117